nicocortonide

Published date: 2024-07-23 13:17:25

nicocortonide Structure
Share to Facebook Share to Twitter Share to Linkedin
Name nicocortonide CAS# 65415-41-0
Price ¥3800.0/3800kg ¥3600.0/3600kg ¥3500.0/3500kg ¥3400.0/3400kg Purity 99.9%
Stocking
Period
1 Day Stock In Stock
 Detail Product Information
Chemical & Physical Properties:
CAS Number: 65415-41-0
Name: nicocortonide
Molecular Formula: C31H37NO7
Molecular Weight: 535.633
Density: N/A
Boiling Point: N/A
Melting Point: N/A
Flash Point: N/A

Supplier/Manufacture

Zhejiang Haomei Pharmaceutical Technology Co. , Ltd.

Chemsrc Level: Unverified
Tel: 18581586485
Address: Room 2810,31 Tianjian port, Shounan Street, Yinzhou District, Ningbo City, Zhejiang province
Area: China
Contact: Zhou Tao
Contact Phone #: 18581586485
Email: 3934275099@qq.com
Website: http://
Major Market:
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:
Zhejiang Haomei Pharmaceutical Technology Co. , Ltd. is a professional manufacturer of pharmaceutical intermediates, registered capital of 10 million yuan, the company“To do a good job in product quality, maintenance of human health” for the purpose, in accordance with the thinking of“Taking benefit as the center, taking quality as the theme, taking management as the main line, taking technical innovation as the motive force, relying on quality to survive, relying on varieties to enter the market”, we bought additional testing instruments, the quality assurance system has been established and improved. Over the years, the company's product market sampling pass rate is 100, in the hearts of dealers and consumers set up a good image, excellent product quality and good reputation for the company to bring brand benefits. The company has been in short supply of Chinese medicine intermediates, product market from the original northeast, southeast more than 20 provinces, cities, regions, to the present 26 provinces, cities, regions, more than 100 large and medium-sized cities, sales revenue and profits tax increase year by year. Production and marketing rate reached 96% . The company actively implements the four strategies of“Attracting investment, structural adjustment, system reform and scientific and technological innovation”, we are prepared to build a pharmaceutical-based enterprise through the introduction of technology, talents, high-tech projects, joint ventures, cooperation and stock expansion, set of drugs, food, beverage-related products as one of the integrated cross-industry group.